TOR complex 2: a signaling pathway of its own
Related Experiment Video
Updated: Jun 19, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Nadine Cybulski1, Michael N Hall
1Biozentrum, University of Basel, 4056 Basel, Switzerland.
Abstract:
Research on TOR has grown exponentially during the last decade, generating a complex model of the TOR signaling network. Rapamycin treatment provides a simple and straightforward method to inhibit the TOR signaling pathway and to study the influence of TOR on multiple cellular processes. The discovery of two distinct TOR complexes, TORC1 and TORC2, showed that studies using rapamycin targeted only one TOR signaling branch. TORC1 is directly inhibited by rapamycin, whereas TORC2 is not. There is no known TORC2-specific inhibitor, so genetic manipulation is required to study its biological function(s). Many studies in genetically tractable model organisms have expanded our understanding of TORC2 signaling. Here we focus on the TORC2 signaling pathway as revealed by these (mostly recent) studies.
Insights
The mechanistic target of rapamycin (TOR) pathway is complex, with two complexes: TORC1 and TORC2. Rapamycin inhibits TORC1, but TORC2 requires genetic methods for study, revealing its crucial cellular roles.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Research on the TOR signaling network has expanded significantly, leading to a complex model.
- Rapamycin is a common inhibitor used to study the TOR pathway's influence on cellular processes.
- The discovery of distinct TOR complexes, TORC1 and TORC2, highlighted that rapamycin selectively inhibits only TORC1.
Purpose of the Study:
- To focus on the TORC2 signaling pathway.
- To review recent studies that have elucidated TORC2 signaling.
- To understand the biological functions of TORC2, for which specific inhibitors are lacking.
Main Methods:
- Review of recent scientific literature focusing on TORC2 signaling.
- Analysis of studies employing genetic manipulation in model organisms to investigate TORC2.
- Synthesis of findings from studies examining the influence of TORC2 on cellular processes.
Main Results:
- TORC1 is directly inhibited by rapamycin, while TORC2 is not.
- Genetic manipulation is necessary to study TORC2 function due to the absence of specific inhibitors.
- Studies in model organisms have significantly advanced the understanding of TORC2 signaling pathways.
Conclusions:
- The TOR signaling network comprises two distinct complexes, TORC1 and TORC2, with differential sensitivity to rapamycin.
- Understanding TORC2 signaling relies heavily on genetic approaches.
- Recent research, particularly in model organisms, has been instrumental in revealing the functions of TORC2.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Intracellular Signaling Cascades
Intracellular Signaling Cascades
Amplifying Signals via Second Messengers
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

